GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » Net Margin %

Rohto Pharmaceutical Co (TSE:4527) Net Margin % : 13.05% (As of Dec. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Rohto Pharmaceutical Co's Net Income for the three months ended in Dec. 2023 was 円9,563 Mil. Rohto Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円73,294 Mil. Therefore, Rohto Pharmaceutical Co's net margin for the quarter that ended in Dec. 2023 was 13.05%.

The historical rank and industry rank for Rohto Pharmaceutical Co's Net Margin % or its related term are showing as below:

TSE:4527' s Net Margin % Range Over the Past 10 Years
Min: 5.34   Med: 6.35   Max: 11.72
Current: 11.72


TSE:4527's Net Margin % is ranked better than
83.76% of 1860 companies
in the Consumer Packaged Goods industry
Industry Median: 3.215 vs TSE:4527: 11.72

Rohto Pharmaceutical Co Net Margin % Historical Data

The historical data trend for Rohto Pharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Net Margin % Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.34 8.18 9.25 10.58 11.05

Rohto Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.81 7.60 14.86 11.25 13.05

Competitive Comparison of Rohto Pharmaceutical Co's Net Margin %

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rohto Pharmaceutical Co's Net Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's Net Margin % falls into.



Rohto Pharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Rohto Pharmaceutical Co's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=26377/238664
=11.05 %

Rohto Pharmaceutical Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=9563/73294
=13.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rohto Pharmaceutical Co  (TSE:4527) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Rohto Pharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rohto Pharmaceutical Co (TSE:4527) Business Description

Traded in Other Exchanges
Address
1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines